文献速递胸部CT

Lung-RADS 1.0 与 1.1 版本比较:基于 NLST 结节的分类变化

Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
PubMed 文献 · Radiology · 2021-05-04

该研究利用 NLST 的 CT 数据,比较 Lung-RADS 1.0 与 1.1 版本对非钙化结节的分类。结果显示 1.1 版将 6 至 <10 mm 的叶间裂旁结节降为 2 类,减少假阳性;而磨玻璃结节大小阈值从 20 mm 增至 30 mm 无获益。

要点

  • Lung-RADS 1.1 将 6 至 <10 mm 的叶间裂旁结节归为 2 类,可减少假阳性。
  • 磨玻璃结节 2 类大小阈值从 20 mm 增至 30 mm 未见获益。
  • 降类磨玻璃结节中可出现恶性,需警惕假阴性。

关键影像表现/征象

  • 1092 个最大实性非钙化结节(≥6 mm 且 <10 mm)中,216 个(19.8%)按 1.1 版判为叶间裂旁结节(2 类)。
  • 161 个磨玻璃结节中,3 个(1.9%)按 1.0 版为 3 类,其中 2 个(66.7%)按 1.1 版降为 2 类。

诊断标准与关键数值

  • Lung-RADS 1.1 将 6 至 <10 mm 的叶间裂旁结节归为 2 类。
  • Lung-RADS 1.1 将 2 类磨玻璃结节大小上限从 20 mm 增至 30 mm。
  • 3 个降类磨玻璃结节中 1 个恶性(假阴性)。
  • 1.1 版对总结节(P < .01)和叶间裂旁结节(P < .01)改善有统计学意义,对磨玻璃结节(P = .48)无统计学意义。

临床应用与阅片要点

  • 阅片时对 6 至 <10 mm 的叶间裂旁结节可按 1.1 版归为 2 类,减少不必要的随访。
  • 对磨玻璃结节即使归为 2 类,也需注意潜在恶性可能,避免漏诊。

局限性

  • 本研究为 NLST 数据的二次分析。
  • 降类磨玻璃结节中出现假阴性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The American College of Radiology updated Lung Imaging Reporting and Data System (Lung-RADS) version 1.0 to version 1.1 in May 2019, with the two key changes involving perifissural nodules (PFNs) and ground-glass nodules (GGNs) now designated as a negative screening result. This study examines the effects of these changes using National Lung Screening Trial (NLST) data. Purpose To determine the frequency of PFNs and GGNs reclassified from category 3 or 4A to the more benign category 2 in the updated Lung-RADS version 1.1, as compared with Lung-RADS version 1.0, using CT scans from the NLST. Materials and Methods In this secondary analysis of the NLST, the authors studied all noncalcified nodules (NCNs) found on the incident scan. Nodules were evaluated using criteria from both Lung-RADS version 1.0 and version 1.1, which were compared to determine changes in the number of nodules deemed benign. A McNemar test was used to assess statistical significance. Results A total of 2813 patients (mean age ± standard deviation, 62 years ± 5; 1717 men) with 4408 NCNs were studied. Of the largest 1092 solid NCNs measuring at least 6 mm but less than 10 mm, 216 (19.8%) were deemed PFNs (category 2) using Lung-RADS version 1.1. Eleven of the 1092 solid NCNs (1.0%) were malignant, but none were PFNs. Of 161 GGNs, three (1.9%) were category 3 according to Lung-RADS version 1.0, of which two (66.7%) were down-classified to category 2 with version 1.1. One of the three down-categorized GGNs (version 1.1) proved to be malignant (false-negative finding). Statistically significant improvement for Lung-RADS version 1.1 was found for total nodules (P < .01) and PFNs (P < .01), but not GGNs (P = .48). Conclusion This secondary analysis of National Lung Screening Trial data shows that Lung Imaging Reporting and Data System version 1.1 decreased the number of false-positive results. This was related to the down-classification of perifissural nodules in the range of 6 up to 10 mm. The increase in allowable nodule size for ground-glass nodules in category 2 from 20 mm (version 1.0) to 30 mm (version 1.1) showed no benefit. © RSNA, 2021 See also the editorial by Mayo and Lam in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kastner J, Hossain R, Jeudy J, et al. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial. Radiology. 2021. PMID: 33944631. doi:10.1148/radiol.2021203704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。